Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer

Gastrin-releasing peptide receptor (GRPR) is overexpressed in the majority of prostate cancers. This study aimed to investigate the potential of (64)Cu (radionuclide for late time-point PET-imaging) for imaging of GRPR expression using NOTA-PEG(2)-RM26 and NODAGA-PEG(2)-RM26. Methods: NOTA/NODAGA-PE...

Descripción completa

Detalles Bibliográficos
Autores principales: Baun, Christina, Mitran, Bogdan, Rinne, Sara S., Dam, Johan H., Olsen, Birgitte B., Tolmachev, Vladimir, Orlova, Anna, Thisgaard, Helge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766840/
https://www.ncbi.nlm.nih.gov/pubmed/33352838
http://dx.doi.org/10.3390/molecules25245993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766840/
https://www.ncbi.nlm.nih.gov/pubmed/33352838
http://dx.doi.org/10.3390/molecules25245993

Ejemplares similares